Breaking Story: FDA Approves SYFOVRE™ for Geographic Atrophy with commentary by Dr. Allen Ho

Dr. Allen Ho of the Wills Eye Hospital and Mid Atlantic Retina in Philadelphia, Pennsylvania joins the podcast to share his thoughts on the recent approval of Apellis Pharmaceuticals’ SYFOVRE™ for geographic atrophy.

Relevant disclosures: Dr Sridhar has consulted with Apellis. Dr Ho has consulted with and been awarded research grants from Apellis, Iveric, and Gyroscope.